• DR. SAL – WEIGHT LOSS DRUG CONTROVERSY - 7 20 24

  • Jul 20 2024
  • Duración: 11 m
  • Podcast

DR. SAL – WEIGHT LOSS DRUG CONTROVERSY - 7 20 24  Por  arte de portada

DR. SAL – WEIGHT LOSS DRUG CONTROVERSY - 7 20 24

  • Resumen

  • FOR MANY PATIENTS, GLP-1 DRUGS LIKE OZEMPIC & WEGOVY LEAD TO SUBSTANTIAL WEIGHT LOSS BUT SOME SEE MUCH LESS BENEFIT AND RESEARCHERS ARE TRYING TO FIGURE OUT WHY? WE SPEAK WITH OUR FRIEND DR. SALVATORE GIORGIANNI, JR., FOUNDER & VP OF HEALTHY MEN, INC. AND THE SENIOR SCIENCE ADVISER TO THE MENS HEALTH NETWORK.
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre DR. SAL – WEIGHT LOSS DRUG CONTROVERSY - 7 20 24

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.